CJC-1295 with DAC is a long-acting GHRH analogue studied for sustained growth-hormone release.
CJC-1295 is a GHRH analogue modified with Drug Affinity Complex (DAC) for extended half-life, researched for sustained stimulation of growth-hormone release. Supplied as a lyophilized research peptide with documentation.
DAC extends the peptide's half-life, allowing longer-acting GH-release research models.
Explore more research peptides from PepNova.
Send your target quantity and specification — we'll return a tailored quote and COA sample.
Request a Quote